Health and Fitness Health and Fitness
Tue, October 19, 2010
[ Tue, Oct 19th 2010 ] - Market Wire
Flamel Technologies Achieves Clinical Milestone w .. xtended Release Formulation of Interferon beta-1a
[ Tue, Oct 19th 2010 ] - Market Wire
Compugen Ltd. to Review Third Quarter 2010 Financial Results on Tuesday, October 26, 2010
Mon, October 18, 2010
[ Mon, Oct 18th 2010 ] - Market Wire
ShangPharma Corporation Announces Pricing of Init .. Public Offering of its American Depositary Shares
[ Mon, Oct 18th 2010 ] - Market Wire
Law Offices of Howard G. Smith Announces Investig .. rs of AGA Medical Holdings, Inc. in Connection wi
[ Mon, Oct 18th 2010 ] - Market Wire
Finkelstein Thompson LLP Announces Investigation of AGA Medical Holdings, Inc.
[ Mon, Oct 18th 2010 ] - Market Wire
Finkelstein Thompson LLP Announces Investigation of China-Biotics, Inc.
[ Mon, Oct 18th 2010 ] - Market Wire
Cubist Announces Offering of Convertible Senior Notes
[ Mon, Oct 18th 2010 ] - Market Wire
Idera Pharmaceuticals to Present at the 17th Annual NewsMakers in the Biotech Industry Conference
[ Mon, Oct 18th 2010 ] - Market Wire
Emeritus Announces Lease Signing for 27 Senior Living Communities
[ Mon, Oct 18th 2010 ] - Market Wire
Columbia Laboratories to Present at the NewsMaker .. e Biotech Industry Conference on October 22, 2010
[ Mon, Oct 18th 2010 ] - Market Wire
SuperGen to Announce 2010 Third Quarter Financial Results on October 25, 2010
[ Mon, Oct 18th 2010 ] - Market Wire
WellCare Announces Senior Management Team Appointments
[ Mon, Oct 18th 2010 ] - Market Wire
The Law Office of Abe Shainberg Launches an Inves .. eaches of Fiduciary Duty by the Board of AGA Medi
[ Mon, Oct 18th 2010 ] - Market Wire
Somaxon Pharmaceuticals Announces Paragraph IV ANDA Filing for Silenor
[ Mon, Oct 18th 2010 ] - Market Wire
Synta Pharmaceuticals to Present at the Newsmakers in Biotechnology Conference
[ Mon, Oct 18th 2010 ] - Market Wire
Apricus Bio Announces First Patent Grant for Femprox® In Japan
[ Mon, Oct 18th 2010 ] - Market Wire
Bronstein, Gewirtz & Grossman, LLC Investigating .. s Law Violations at Gentiva Health Services, Inc.
[ Mon, Oct 18th 2010 ] - Market Wire
LifePoint Hospitals to Broadcast Its Third Quarter 2010 Conference Call Live on the Internet
[ Mon, Oct 18th 2010 ] - Market Wire
The Briscoe Law Firm Investigates AGA Medical Hol .. , Inc. Concerning the Buy-Out by St. Jude Medical
[ Mon, Oct 18th 2010 ] - Market Wire
American CareSource Holdings Adds Insurance Management Administrators Client Portfolio
[ Mon, Oct 18th 2010 ] - Market Wire
Faruqi & Faruqi, LLP Announces Investigation Rela .. Acquisition of AGA Medical Holdings, Inc. - AGAM
[ Mon, Oct 18th 2010 ] - Market Wire
Kendall Law Group Investigates AGA Medical Holdings, Inc. Acquisition for Shareholders
[ Mon, Oct 18th 2010 ] - Market Wire
U.S. Food and Drug Administration Approves BARACL .. nt for Chronic Hepatitis B Patients with Evidence
[ Mon, Oct 18th 2010 ] - Market Wire
Teva Announces Launch of Generic Prevacid® SoluTab in the United States
[ Mon, Oct 18th 2010 ] - Market Wire
Tenet Hospitals Awarded 205 CIGNA HealthCare Quality Designations
[ Mon, Oct 18th 2010 ] - Market Wire
Zynex Increases Board of Directors
[ Mon, Oct 18th 2010 ] - Market Wire
Thermo Fisher Scientific Forms Scientific Advisory Board
[ Mon, Oct 18th 2010 ] - Market Wire
XIFAXAN 550 mg (Rifaximin) Demonstrates Acute and .. stipation Irritable Bowel Syndrome Symptoms: Data
[ Mon, Oct 18th 2010 ] - Market Wire
Mergenet Medical Launches Trach-Assist® First Airway Secretion Management System of Its Kind
[ Mon, Oct 18th 2010 ] - Market Wire
Micromet to Present at the 2010 Newsmakers in the Biotechnology Industry Conference

Micromet to Present at the 2010 Newsmakers in the Biotechnology Industry Conference


Published on 2010-10-18 05:40:31 - Market Wire
  Print publication without navigation


BETHESDA, Md.--([ BUSINESS WIRE ])--Micromet, Inc. (Nasdaq:MITI), a biopharmaceutical company focused on the development and commercialization of next-generation antibodies for the treatment of cancer, announced today that the Company will participate in the 2010 Newsmakers in the Biotechnology Industry Conference, to be held on October 22, 2010 in New York City. Christian Itin, Ph.D., the Companya™s President and CEO, will present a 25 minute corporate overview at 2:30 PM ET.

The presentation will be webcast live and may be accessed by visiting the Micromet website at [ www.micromet.com ]. A replay of the webcast will also be available on the Company's website.

About Micromet, Inc.

Micromet, Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of innovative antibody-based therapies for the treatment of cancer. Its product development pipeline includes novel antibodies generated with its proprietary BiTE® technology, as well as conventional monoclonal antibodies. The Companya™s lead product candidate blinatumomab (MT103) is currently the subject of a European pivotal trial in patients with minimal residual disease positive acute lymphoblastic leukemia. Micromet has collaborations with a number of leading pharmaceutical and biotechnology companies, including Bayer Schering Pharma, Boehringer Ingelheim, MedImmune, Merck Serono, Nycomed and sanofi-aventis. Additional information can be found at [ www.micromet.com ].

Contributing Sources